Andy Ni (Ai Ni)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2016-2023
Publications (10 Years): 7

Top Topics

Monoclonal Antibody

Top Venues

Leukemia & lymphoma

Statistics in medicine

JMIR research protocols

Lifetime data analysis

This page only lists publications with an associated author ORCID identifier.

Publications

Andy Ni, Mengling Liu, Li-Xuan Qin
BatMan: Mitigating Batch Effects Via Stratification for Survival Outcome Prediction. JCO clinical cancer informatics 7 (2023)
Xiaohan Guo, Andy Ni
Contrast weighted learning for robust optimal treatment rule estimation. Statistics in medicine 41 (27) (2022)
Thais Fischer, Andy Ni, Kurt S Bantilan, Jacob D Soumerai, Anna Alperovich, Connie Lee Batlevi, Anas Younes, Andrew D Zelenetz
The impact of anti-CD20-based therapy on hypogammaglobulinemia in patients with follicular lymphoma. Leukemia & lymphoma 63 (3) (2022)
Andy Ni, Li-Xuan Qin
Performance evaluation of transcriptomics data normalization for survival risk prediction. Briefings in bioinformatics 22 (6) (2022)
Kristen M Sarlo, Brianne N Dixon, Andy Ni, David J Straus
Incidence of infectious complications with the combination of bendamustine and an anti-CD20 monoclonal antibody. Leukemia & lymphoma 61 (2) (2019)
Andy Ni, Jianwen Cai
A regularized variable selection procedure in additive hazards model with stratified case-cohort design. Lifetime data analysis 24 (3) (2017)
David N Cavallo, Jessica A Sisneros, Ashley A Ronay, Cheryl L Robbins, Stephanie Jilcott Pitts, Thomas C Keyserling, Andy Ni, John Morrow, Maihan B Vu, Larry F Johnston, Carmen D Samuel-Hodge
Assessing the Feasibility of a Web-Based Weight Loss Intervention for Low-Income Women of Reproductive Age: A Pilot Study. JMIR research protocols 5 (1) (2016)